BUSE, JOHN

Letters

Determination of GlaxoSmithKline, PLC, action after receiving study on the potential health risks associated with diabetes drug Avandia: Senator Grassley, Committee on Finance (Senate), S486 [30JA]

Remarks in Senate

Pharmaceuticals: potential health risks associated with diabetes drug Avandia, S486 [30JA]